Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Birth Weight

• Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection.
• Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
• Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial
• Effect of Zinc Supplementation on Neonatal Mortality and Morbidities in Very Low Birth Weight Infants
• Iron Supplementation and Intestinal Health
• Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia
• Omega 3 Plus Vaginal Progesterone on Birth Weight of Intrauterine Growth-restricted Fetuses
• Zinc Supplementation on Very Low Birth Weight Infant
• IgM-Enriched Immunoglobulin for Neonatal Sepsis
• Micronutrient Supplementation Before and During 1st Pregnancy to Improve Birth Outcomes (JiVitA-5)
• Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants
• 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
• Extremely Low Gestatonal Age Infants' Paracetamol Study
• Bovine Lactoferrin and Neonatal Survival in Low Birth Weight Babies.
• Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates
• Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants
• Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity
• Preterm Infant Inhaled Albuterol Dosing
• Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.
• Nplate® Pregnancy Exposure Registry
• Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)
• Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
• Sodium Supplementation and Growth in Very Low Birth Weight Infants
• Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants
• The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
• Pharmacokinetic Study of Fluconazole in Premature Infants
• Effects of Recto-colic Enemas of Butyrate on the Digestive Disorders of Very Low Birth Weight Preterms <1250 Grams
• Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants
• Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants
• Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants
• Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
• Study of a Model-based Approach to Blood Glucose Control in Very-low-birthweight Neonates
• Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants
• Oral Ibuprofen Prophylaxis for Patent Ductus Arterioses in Very Extremely Low Birth Weight Infants
• Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?
• Hydrocortisone for BPD
• Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight Infants
• Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants
• Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants
• Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
• The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
• Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
• Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
• Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
• Vitamin E for Extremely Preterm Infants
• Supplementation With Lactoferrin in Preterm Newborns
• Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
• Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth Weight
• Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants
• Early Blood Pressure Management in Extremely Premature Infants
• Tolerance of Increased Infusion Rates of Intravenous Fat Emulsions in Very Low Birth Weight Infants
• Timing of Iron Supplementation in Very Low Birth Weight Infants
• Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
• Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
• Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants
• Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates
• Erythropoietin Treatment in Extremely Low Birth Weight Infants
• Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia
• Iron Supplementation of Marginally Low Birth Weight Infants
• Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
• Montelukast in Very Low Birthweight Infants
• Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies
• Vitamin A and Very Low Birthweight Babies (VitAL)
• Effect of Vitamin D Supplementation on Health of Low Birth Weight Infants
• Post Discharge Human Milk Fortifier in Preterm Infants
• Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants
• Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
• Two Strategies of RDS Treatment in Newborns With Birth Weight > 1500 Grams
• Impact of Zinc Supplementation in Low Birth Weight Infants on Severe Morbidity, Mortality and Zinc Status: A Randomized Controlled Trial
• Surfactant Positive Airway Pressure and Pulse Oximetry Trial
• SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
• Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
• Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy
• Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women
• Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
• Trial of Nutritional Supplementation in Infants Born Small for Gestational Age
• Effect of Caffeine on Fetal Growth
• Antenatal Micronutrient Supplementation and Birth Weight
• Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
• Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial
• Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
• Dexamethasone Therapy in VLBW Infants at Risk of CLD
• Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)
• Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage
• Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion
• Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
• Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants